Eisai stock slumps after Alzheimer’s drug fails to get approval in Europe
Eisai shares fell sharply after its Alzheimer’s drug failed to secure marketing approval in the European Union.
—————
Boost Internet Speed–
Free Business Hosting–
Free Email Account–
Dropcatch–
Free Secure Email–
Secure Email–
Cheap VOIP Calls–
Free Hosting–
Boost Inflight Wifi–
Premium Domains–
Free Domains
